Literature DB >> 6116780

Degradation of chlorambucil in aqueous solution--influences of human albumin binding.

H Ehrsson, U Lönroth, I Wallin, M Ehrnebo, S O Nilsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6116780     DOI： 10.1111/j.2042-7158.1981.tb13787.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  10 in total

1.  Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.

Authors:  Robert A Parise; Bean N Anyang; Julie L Eiseman; Merrill J Egorin; Joseph M Covey; Jan H Beumer
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-05       Impact factor: 3.333

2.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Effect of food on pharmacokinetics of chlorambucil and its main metabolite, phenylacetic acid mustard.

Authors:  H Ehrsson; I Wallin; B Simonsson; P Hartvig; G Oberg
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Chlorambucil: stability of solutions during preparation and storage.

Authors:  A G Bosanquet; H E Clarke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Pharmacokinetic and metabolic studies of busulfan in rat plasma and brain.

Authors:  M Hassan; H Ehrsson; I Wallin; S Eksborg
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

6.  Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil.

Authors:  S Genka; J Deutsch; U H Shetty; P L Stahle; V John; I M Lieberburg; F Ali-Osman; S I Rapoport; N H Greig
Journal:  Clin Exp Metastasis       Date:  1993-03       Impact factor: 5.150

7.  Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration.

Authors:  N H Greig; S Genka; E M Daly; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Pharmacokinetics of peptichemio in myeloma patients: release of m-L-sarcolysin in vivo and in vitro.

Authors:  H Ehrsson; R Lewensohn; I Wallin; M Hellström; G Merlini; B Johansson
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 9.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

10.  Chlorambucil-monoglutathionyl conjugate is sequestered by human alpha class glutathione S-transferases.

Authors:  D J Meyer; K S Gilmore; J M Harris; J A Hartley; B Ketterer
Journal:  Br J Cancer       Date:  1992-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.